GE (NYSE: GE) announced plans in early November 2021 to split into three separate companies over the next few years, including a separate GE Healthcare.

Boston-based GE will run tax-free spin-offs of Healthcare in early 2023 and a renewable energy and energy company in early 2024. The remaining GE will become an aviation-focused company after transactions.

"By creating three industry-leading global public companies, each can benefit from increased focus, customized capital allocation and strategic flexibility to drive long-term growth and value for customers, investors and employees," said GE CEO H Lawrence Culp Jr. said in a press release.

Philips (NYSE: PHG) today announced that it has signed an agreement with a cardiologist to acquire its artificial intelligence (AI) technology.

In a press release from Amsterdam-based Philips, France-based cardiologists and their cloud and artificial intelligence technologies further enhance cardiac monitoring and diagnostic services with innovative software, ECG analysis and reporting services. I said.

Founded in 2014, Cardiologists currently employs approximately 70 people and is primarily composed of software engineers and computer scientists. These employees will join Philips to expand their AI-focused innovation activities at the R & D Lab in Paris.

Coloplast will spend 16 billion Danish kroner. (approximately $ 2.4 billion) to acquire laryngectomy care device company Atos Medical.

The Danish medical technology giant in a press release on Monday said Atos Medical's goal of making life easier for people living with a neck stoma is closely aligned with Coloplast's purpose of serving people with health needs. intimate health care.

PAI Partners, a Paris-based private equity firm, is the current owner of Atos Medical, based in Malmö, Sweden. Company officials expect the deal to close early next year during Coloplast's second quarter of fiscal year 2021-22, pending customary regulatory approvals. 

Atos Medical will operate as a separate strategic business unit within Coloplast once the agreement is completed. It currently has a presence in 22 countries, including a U.S. office in New Berlin, Wisconsin.

Alcon (NYSE: ALC) announced early November 2021 that it plans to pre-acquire glaucoma surgical instrument manufacturer Ivantis for $ 475 million.

Based in Geneva, Switzerland, Alcon aims to strengthen its cataract, refraction, retina and glaucoma product portfolio by acquiring Ivantis and the new Hydrus Microstent (MIGS) for minimally invasive glaucoma surgery.

The FDA approved Hydros Microstent for use in combination with cataract surgery in the United States in August 2018, but with primary open-angle glaucoma in combination with cataract surgery or stand-alone in the United Kingdom, Canada, Australia and Singapore. Adapted as a procedure. And Germany.

Archon will prepaid $ 475 million and may need to make additional conditional payments after reaching certain regulatory and business milestones. The company plans to close the transaction in the first quarter of 2022.